Jan 01–04, 2027 | Location to be Determined
Scientific Organizers:
Christina Woo, William Forrester, and Alessio Ciulli

-
Scientific Organizers: Christina Woo, William Forrester, and Alessio Ciulli
Christina Woo
William Forrester
Alessio Ciulli
***Meeting program subject to change.
Available Formats: = In Person = On DemandFriday, January 1, 2027
Merchandise Options
Registration Options
Saturday, January 2, 2027
Regulated Induced Proximity Targeting Chimeras—RIPTACs—A Heterobifunctional Small Molecule Strategy for Cancer Selective Therapies: Cell Chemical Biology
Neurodegenerative Targets in TPD
Solving Big Problems with Small Molecule Degraders
The Novartis Targeted Protein Degradation Platform
Clinical Development of Nurix’s Degrader Drugs
Any Target, Every Time
Shuttle Proteins
Pervasive Mislocalization of Pathogenic Coding Variants Underlying Human Disorders: Cell
Sunday, January 3, 2027
Haven't Got a Glue: Protein Surface Variation for the Design of Molecular Glue Degraders
E3 Ligase and Degrader Discovery
C-Terminal Amides Mark Proteins for Degradation via SCF–FBXO31
Probing Cereblon Allosterically
Trivalent TAC Chemistry
A Pharmacological Modality to Sequester Homomeric Proteins
Chemical Immunology and Proteomics for Small Molecule Degraders
Monday, January 4, 2027
Cell Surface Induced Proximity Engineering
Degrader Delivery through CD36
Delving into Novel Design and Development to Strive for Next-Generation ADCs Providing Long-Term Benefit to Patients
PP Interface
Adventures in CADD
AI-Driven Drug Discovery
Future of PPIs
Tuesday, January 5, 2027
Subscribe for Updates